E. Keystone

Extended report: Evidence for treating rheumatoid arthritis to target: results of a systematic literature search

D. Heijde, R. Knevel, D. Aletaha, 2010 .

Two Dosing Regimens of Certolizumab Pegol in Patients With Active Rheumatoid Arthritis

B. Devellis, B. Gandek, R. Devellis, 2015, Arthritis care & research.

Having More Tender Than Swollen Joints Is Associated With Worse Patient-Reported Outcomes in Patients With Early RA.

O. Schieir, V. Bykerk, M. Valois, 2024, Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases.

Having More Tender Than Swollen Joints is Associated With Worse Function and Work Impairment in Patients With Early Rheumatoid Arthritis.

O. Schieir, V. Bykerk, M. Valois, 2024, ACR Open Rheumatology.

Updated consensus statement on biological agents, specifically tumour necrosis factor α (TNFα) blocking agents and interleukin-1 receptor antagonist (IL-1ra), for the treatment of rheumatic diseases, 2005

P. Mease, J. Smolen, G. Burmester, 2004 .

FRI0068 102-wk clinical and radiologic results from the attract trial: a 2 year, randomised, controlled, phase 3 trial of infliximab (remicade®) in pts with active ra despite mtx

D. M. van der Heijde, F. Breedveld, J. Smolen, 2001 .

Granulomatous hypophysitis due to Wegener's granulomatosis.

W. Kucharczyk, E. Keystone, M. Goyal, 2000, AJNR. American journal of neuroradiology.

A Bridge Too Far? Real‐World Practice Patterns of Early Glucocorticoid Use in the Canadian Early Arthritis Cohort

O. Schieir, E. Keystone, V. Bykerk, 2021, ACR open rheumatology.

Extended Report

W. Dixon, S. Suissa, A. Kezouh, 2022 .

Risk factors for prevalent and incident hypertension in rheumatoid arthritis: data from the Canadian Early Arthritis Cohort

O. Schieir, V. Bykerk, M. Valois, 2024, Rheumatology advances in practice.